On the other hand, GSK-3β also functions as a negative regulator of pro-inflammatory cytokine expression [92], [93] and decreased GSK-3β expression may render Pink1−/− mice more vulnerable to TNF-α, IL-1β and LPS-induced brain inflammation [88], [91], [94]. The gene discussed is GSK3B; the disease is brain inflammatory disease.